Ask AI
ProCE Banner Activity

Changing Gastrointestinal Cancer Care—Highlights From the 2025 ASCO Annual Meeting

Conference Coverage
Clinical Thought

Read how results from the ATOMIC, MATTERHORN, and CHALLENGE clinical trials are changing expert clinical practice for patients with resectable gastrointestinal cancers.

Released: August 26, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Daiichi Sankyo, Inc. and Genentech, a member of the Roche Group.

Daiichi Sankyo, Inc.

Genentech, a member of the Roche Group

Faculty Disclosure

Primary Author

James M. Cleary, MD, PhD: consultant/advisor/speaker: Abdera, BeOne, Gilead, Prelude; researcher: Amgen, Arcus, BMS, GlaxoSmithKline, Merck, Merus, Pyxis, Servier; data and safety monitoring committee: AstraZeneca.